INMB INmune Bio, Inc.
$2.17
INmune Bio, Inc. (INMB) is expected to report earnings on November 5, 2026, after the market close.
INmune Bio Reported Earnings
Thursday, August 6, 2026 · 4:00 PM ET
Earnings Date
Nov 5
Thursday · 4:05 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
-
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About INmune Bio, Inc.
INmune Bio, Inc. is a clinical-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease.
Sector
Healthcare
Industry
Biotechnology